354 related articles for article (PubMed ID: 2253318)
1. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
Qi M; Jones SB
Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
[TBL] [Abstract][Full Text] [Related]
2. Plasma catecholamines during endotoxin infusion in conscious unrestrained rats: effects of adrenal demedullation and/or guanethidine treatment.
McKechnie K; Dean HG; Furman BL; Parratt JR
Circ Shock; 1985; 17(1):85-94. PubMed ID: 3902274
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
[TBL] [Abstract][Full Text] [Related]
4. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Toth PD; Mikulaschek AW
Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
[TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
[TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
Bouvier C; Guc MO; Furman BL; Parratt JR
Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
[TBL] [Abstract][Full Text] [Related]
7. Dose- and time-dependent changes in plasma catecholamines in response to endotoxin in conscious rats.
Jones SB; Romano FD
Circ Shock; 1989 May; 28(1):59-68. PubMed ID: 2731322
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor antagonists in experimental shock.
Muacevic G; Heuer HO
Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
[TBL] [Abstract][Full Text] [Related]
9. Lipoxygenase and cyclooxygenase blockade by BW755C prevents endotoxin-induced hypotension but not changes in glucose metabolism.
Lang CH; Blakesley HL; Bagby GJ; Spitzer JJ
Horm Metab Res; 1988 Sep; 20(9):551-4. PubMed ID: 3143653
[TBL] [Abstract][Full Text] [Related]
10. Plasma catecholamines in the conscious rat during endotoxicosis.
Jones SB; Romano FD
Circ Shock; 1984; 14(3):189-201. PubMed ID: 6391720
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
13. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
Salari H; Demos M; Wong A
Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
[TBL] [Abstract][Full Text] [Related]
14. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
Natsume Y; Imanishi N; Koike H; Morooka S
Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
16. Effects of naloxone and thyrotropin-releasing hormone on plasma catecholamines, corticosterone, and arterial pressure in normal and endotoxemic rats.
Long JB; Lake CR; Reid AA; Holaday JW
Circ Shock; 1986; 18(1):1-10. PubMed ID: 3080257
[TBL] [Abstract][Full Text] [Related]
17. Modification by oxygen free radical scavengers of the metabolic and cardiovascular effects of endotoxin infusion in conscious rats.
McKechnie K; Furman BL; Parratt JR
Circ Shock; 1986; 19(4):429-39. PubMed ID: 3742740
[TBL] [Abstract][Full Text] [Related]
18. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
Li SH; Fei X; Gong XQ; Wu ZL
Yao Xue Xue Bao; 1991; 26(1):6-9. PubMed ID: 1887797
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis.
Yoo J; Schlondorff D; Neugarten J
J Pharmacol Exp Ther; 1991 Mar; 256(3):841-4. PubMed ID: 2005583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
